
Pear Bio
Patient-centered Cancer Precision Medicine.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredOct 19, 2019 (7 years old)
About Pear Bio
Delivering functional precision medicine guided therapeutics to patients with hard-to-treat cancers
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Companies like Pear Bio
NNewLimit$435M Series B+ · Jun 2026
OOncoPrecision
NNula Therapeutics$20M Seed · Mar 2026
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
TTheradaptiveSeries A · Jul 2025
LLUCA Science$30M Series B+ · Jun 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/pear-bio (get a free API key).